<- Back to digest

Arthroscopy - 2026-10-16 - Journal Article

Patients Aged ≥60 Years Achieve Comparable Improvement but Lower Patient Acceptable Symptom States After Hip Arthroscopy for Femoroacetabular Impingement Syndrome Using Contemporary Techniques: A Propensity Score-Matched Cohort Study.

Vega TF, Sparks CA, Casanova F, Bi AS, Alfonsi S, Nho SJ, Chahla J

retrospective cohortLOE IIIn = 143 patients (139 hips in ≥60 cohort, 95 hips in 18-40 cohort); 48 older patients matched 1:2 to 91 younger patientsMean 27.1 months (≥60 cohort), 27.5 months (younger cohort); minimum 12 months.

Topics

sports
PMID: 42885667DOI: 10.1002/arj.70631View on PubMed ->

Key Takeaway

Patients ≥60 years undergoing hip arthroscopy for FAI achieved comparable MCID rates across all PROs but significantly lower HOS-ADL PASS rates versus matched younger controls (47.6% vs 71.6%, P=.015) at mean 27-month follow-up.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This propensity score-matched retrospective study compared hip arthroscopy outcomes for FAI syndrome in patients ≥60 years versus 18-40 years, controlling for sex, BMI, and Tönnis grade, with all patients undergoing labral repair and capsular closure. Both cohorts achieved significant improvement across HOS-ADL, HOS-SS, and iHOT-12 (P<.001), with comparable MCID achievement and similar HOS-SS and iHOT-12 PASS rates. However, the ≥60 cohort had lower baseline and postoperative HOS-ADL scores (53.0 vs 63.8 preop; 76.8 vs 87.3 postop) and a significantly lower HOS-ADL PASS rate (47.6% vs 71.6%), with 93.8% reoperation-free survivorship at 27 months driven by failure in patients with Tönnis grade 1, bipolar cartilage lesions, and grade ≥2 cartilage damage.

Key Limitation

The minimum 12-month follow-up is insufficient to capture late cartilage-driven failures and conversion to arthroplasty, which are the most clinically consequential endpoints in a ≥60-year-old population.

Original Abstract

PURPOSE

To compare patients ≥60 years and ≤40 years old undergoing contemporary hip arthroscopy for femoroacetabular impingement syndrome managed with labral repair and capsular closure using a propensity score-matched cohort design controlling for sex, body mass index, and Tönnis grade.

METHODS

A single-center retrospective review identified patients ≥60 years undergoing primary hip arthroscopy for femoroacetabular impingement syndrome (January 2015-May 2024) with a minimum 12-month follow-up. Exclusion criteria included prior ipsilateral surgery, non-femoroacetabular impingement syndrome pathology, Tönnis grade ≥2, concomitant procedures, osteotomy, Ehlers-Danlos syndrome, and isolated labral debridement. Patients were matched 1:2 by sex, body mass index, and Tönnis grade to those aged 18 to 40 years. Patient-reported outcomes included pre- and postoperative Hip Outcome Score-Activities of Daily Living (HOS-ADL), Hip Outcome Score Sports-Specific subscale, and 12-Item International Hip Outcome Tool. Cohort-specific minimal clinically important difference, patient acceptable symptom state (PASS), and reoperation-free survivorship were assessed.

RESULTS

Forty-eight patients (48 hips) ≥60 years (63.7 ± 3.6 years; follow-up 27.1 [12.0-72.0] months) were matched to 91 patients (95 hips) 18 to 40 years (31.6 ± 3.5 years; follow-up 27.5 [12.0-65.2] months). Both groups improved across all patient-reported outcomes (P < .001). Hip Outcome Score Sports-Specific subscale and 12-Item International Hip Outcome Tool were comparable pre- and postoperatively (P > .05). The ≥60 cohort had lower HOS-ADL at baseline (53.0 ± 21.3 vs 63.8 ± 18.2, P = .006) and postoperatively (76.8 ± 23.2 vs 87.3 ± 14.5, P = .002). Minimal clinically important difference achievement and score improvements were similar (P > .05), as were PASS rates for Hip Outcome Score Sports-Specific subscale and 12-Item International Hip Outcome Tool. HOS-ADL PASS was lower in the ≥60 cohort (47.6% vs 71.6%, P = .015). Survivorship was 93.8% in the ≥60 cohort versus 100% in controls, with reoperations occurring in patients with baseline Tönnis grade 1, bipolar cartilage lesions, and grade ≥2 cartilage lesions.

CONCLUSIONS

Patients ≥60 years achieved comparable improvement and minimal clinically important difference rates but lower absolute function and HOS-ADL PASS rates. Survivorship was 94% at 27 months (minimum 12), with failure driven by cartilage damage. Meaningful improvement is achievable in appropriately selected older patients, although expectations and outcome thresholds may differ by age.

LEVEL OF EVIDENCE

Level III, retrospective comparative cohort study.